Korea vs Sao Tome and Principe: Prevalence rate of diabetes in adults
Korea
8
in 2014
Sao Tome and Principe
8
in 2014
Korea rank
97th
Sao Tome and Principe rank
97th
Prevalence rate of diabetes in adults over time
- Korea
- Sao Tome and Principe
How they compare
Korea currently reports 8 against 8 in Sao Tome and Principe, a difference of 0.
The two have swapped places 2 times across 35 shared years of data; in 1980 it was Sao Tome and Principe ahead.
Korea ranks 97th and Sao Tome and Principe ranks 97th of 190 countries.
Across the 4 decades both report, Korea averaged higher in 3 and Sao Tome and Principe in 1.
Head to head by decade
| Decade | Korea | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 5.18 | 4.63 | 0.55 | Korea |
| 1990s | 7.05 | 6.22 | 0.83 | Korea |
| 2000s | 7.37 | 7.25 | 0.12 | Korea |
| 2010s | 7.74 | 7.88 | 0.14 | Sao Tome and Principe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of diabetes in adults, Korea or Sao Tome and Principe?
- Korea, at 8 against 8 in Sao Tome and Principe as of 2014.
- What is the difference in prevalence rate of diabetes in adults between Korea and Sao Tome and Principe?
- 0, with Korea ahead.
- How many years of comparable data are there for Korea and Sao Tome and Principe?
- 35 years are reported by both, from 1980 to 2014.
- How do Korea and Sao Tome and Principe rank globally for prevalence rate of diabetes in adults?
- Korea ranks 97th and Sao Tome and Principe ranks 97th of 190 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) β with minor processing by Our World in Data, published as Prevalence rate of diabetes in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of people with diabetes among those aged over 18, based on general population surveys and statistical modeling. Diabetes is a risk factor for chronic complications, including cardiovascular disease, and premature death.